HIV-1 Vpu modulates cellular transmembrane proteins to optimize viral replication and provide immune-evasion, triggering ubiquitin-mediated degradation of some targets but also modulating endosomal trafficking to deplete them from the plasma membrane. Interactions between Vpu and the heterotetrameric clathrin adaptor protein (AP) complexes AP-1 and AP-2 have been described, yet the molecular basis and functional roles of such interactions are incompletely defined. To investigate the trafficking signals encoded by Vpu, we fused the cytoplasmic domain (CD) of Vpu to the extracellular and transmembrane domains of the CD8 α-chain. CD8-VpuCD was rapidly endocytosed in a clathrin-and AP-2-dependent manner. Multiple determinants within the Vpu CD contributed to endocytic activity, including phosphoserines of the β-TrCP binding site and a leucine-based ExxxLV motif. Using recombinant proteins, we confirmed ExxxLV-dependent binding of the Vpu CD to the α/σ2 subunit hemicomplex of AP-2 and showed that this is enhanced by serine-phosphorylation. Remarkably, the Vpu CD also bound directly to the medium (μ) subunits of AP-2 and AP-1; this interaction was dependent on serine-phosphorylation of Vpu and on basic residues in the μ subunits. We propose that the flexibility with which Vpu binds AP complexes broadens the range of cellular targets that it can misdirect to the virus' advantage.
The accessory proteins Vpu and Nef alter the content of the plasma membrane through modulation of cellular transmembrane proteins. Targets of Vpu and Nef include restriction factors such as bone marrow stromal antigen 2 (BST-2, also known as tetherin), which physically tethers newly budded virions to the plasma membrane, 1,2 as well as immuno-receptors such as CD4, which functions as the virus' primary receptor for entry into cells but which also inhibits viral infectivity 3, 4 and sensitizes the viral envelope glycoprotein to host antibodies if unperturbed by Vpu and Nef during virionproduction. 5, 6 Vpu and Nef divide the task of modulating the plasma membrane in a manner that is distinct yet shares certain features, both in terms of the host proteins targeted and in terms of mechanism of action (reviewed by Ref. 7) . For example, Vpu and Nef each target CD4. In contrast, in a given virus, one or the other protein targets BST-2: Vpu targets BST-2 in most group M HIV-1 strains (the main cause of the pandemic), but in group O (outlier) strains, as well as in most strains of simian immunodeficiency virus, this activity is subsumed by Nef. [8] [9] [10] Vpu and Nef are structurally dissimilar, yet both act at least partly via clathrin and clathrin adaptors. Nef is a 27 kDa N-terminally myristoylated peripheral membrane protein; it 18, 19 The activity of Vpu, at least with respect to BST-2, is also clathrin-dependent. [20] [21] [22] Vpu-mediated downregulation of BST-2 from the cell surface is partly dependent on AP-2, 20 and surface downregulation as well as the ability of Vpu to counteract BST-2-mediated restriction of virion-release is reversed by expression of a dominant version of the clathrin assembly factor AP180. 21, 22 Moreover, group M Vpu proteins of subtype B strains contain an ExxxLV sequence within the membrane distal α-helix; this sequence resembles a variant ExxxLφ motif that is recognized by AP complexes. 22 We have shown that this Vpu sequence binds in an extended conformation to the canonical recognition site on the σ (small) and γ (largespecific) subunits of AP-1 and that this interaction is stabilized when the BST-2 CD, which contains a variant Yxxφ AP-binding sequence, is bound to the tyrosine-binding pocket of the AP-1 μ subunit. 23 Binding of the Vpu CD to an AP-2 hemicomplex formed by α and σ2 subunits, as well as to the μ2 subunit, was also observed in vitro. 23 Recently, interactions between Vpu and both AP-1 and AP-2 have been detected in human cells by biotinylation-proximity and chemical cross-linking/immunoprecipitation assays. 24 Like some of the interactions detected using recombinant proteins, these in vivo interactions of Vpu with AP complexes also required the presence of BST-2.
Remarkably, these in vivo interactions required not only Vpu's ExxxLV sequence but also phosphorylation of the key serines noted above, leading to a model in which phosphorylation induces conformational changes that allow binding of the ExxxLV sequence to AP-2. enced by the presence of BST-2, whereas wild-type Vpu is not. 22 Vpu causes a net surface downregulation of its targets, yet a clear role for stimulation of endocytosis is lacking; rather the preponderance of current data suggest that the primary role of Vpu is to sequester targeted proteins within the endosomal system, either within the biosynthetic pathway or through inhibition of recycling to the plasma membrane following constitutive endocytosis.
In this investigation, we fused the CD of Vpu to the extracellular/lumenal and TMDs of the CD8 α-chain and used this chimera to study the trafficking properties of the Vpu CD independently of cellular targets that interact with Vpu via its TMD. We determined that the Vpu CD provides endocytic activity equal to or greater than that of Nef, but that unlike Nef, which relies wholly on its ExxxLL sequence, endocytic activity is distributed among multiple determinants in the Vpu CD. The rapid endocytic rate conferred by the Vpu CD requires clathrin and the clathrin-adaptor AP-2. Finally, we determined that the serines 52 and 56 in the Vpu CD probably contribute to these effects through 2 mechanisms. Serine phosphorylation enhances binding of the ExxxLV motif to the AP-2 hemicomplex of α/σ2 subunits, consistent with recent structural and functional studies. 23, 24 In addition, the phosphoserines mediate direct binding to the μ subunit of AP complexes, recognizing basic patches on the μ subunits of both AP-2 and AP-1. We have previously shown that these basic patches (on the μ subunit of AP-1) are recognized by Nef when complexed with the CD of the class I major histocompatibility complex (MHC) α chain. 25 Thus, our data reveal a striking convergence in how these 2 very different viral proteins co-opt clathrin adaptors.
Our data confirm a duality in which the key serines in Vpu act both as a phosphodegron via the cullin1-based E3 ligase complex and in regulating the association of Vpu with clathrin AP complexes. Moreover, the data reveal a bimodal mechanism for the phosphoserinedependent interaction of Vpu with AP complexes: the phosphoserines not only facilitate binding of the ExxxLV motif to AP hemicomplexes, but also they are part of a phosphoserine-acidic cluster that mediates binding to basic patches on the μ subunits.
2 | RESULTS
| The CD of Vpu contains endocytic determinant(s)
To determine whether the CD of Vpu contains endocytic determinants that function autonomously, and in particular independently of such determinants that might be present in the CDs of Vpu's cellular targets, we created a chimeric protein comprising residues 28-81 of HIV-1 NL4.3 Vpu fused to the extracellular/lumenal and TMDs (residues 1-212) of the human CD8 α-chain (as shown in Figure 1A ). This and similar strategies have been used previously to evaluate autonomous sorting signals in the CDs of cellular proteins and to evaluate the trafficking activity of HIV-1 Nef. [26] [27] [28] [29] HeLa-P4.R5 cells, which express CD4, were transiently transfected to express the CD8-VpuCD chimera, a truncated CD8 lacking most of its CD as a control, CD8-Nef, or CD8-Nef-LL/AA, which due to alanine substitutions of the conserved dileucine motif at Nef-positions 164 and 165 is unable to interact with the clathrin adaptor complex AP-2. Cell surface expression of the chimeric proteins was measured by flow cytometry after staining for CD8 ( Figure 1B ,C). The mean fluorescence intensity (MFI) of CD8-VpuCD or CD8-Nef at the cell surface was reduced in cells relative to truncated CD8-or CD8-Nef-LL/AA. The high surface expression of CD8-Nef-LL/AA is consistent with previous observations and the critical role of Nef's dileucine motif in binding to clathrin adaptors, in particular AP-2. 28 The expression of the chimeras at steady-state was assessed by western blot ( Figure 1D ). The addition of the VpuCD or Nef appeared to stabilize expression, while the expression of truncated CD8 was relatively low. CD8-Nef and CD8-Nef-LL/AA were expressed at equal levels. These data demonstrated that the surface expression of the chimeric proteins is independent of total cellular protein concentration and probably depends upon the trafficking properties of their CDs.
The low surface expression of CD8-VpuCD indicated either that the protein was retained in the biosynthetic pathway or that it was specifically endocytosed from the cell surface, or both. To test the hypothesis that the VpuCD stimulates endocytosis, we compared the internalization rates of CD8-, CD8-VpuCD, CD8-Nef and CD8-Nef-LL/AA in transiently transfected HeLa-P4.R5 cells. The endocytic rates of the chimeric proteins were also compared to that of FIGURE 1 The cytoplasmic domain of NL4.3 Vpu contains endocytic determinant(s). A, Fusions of human CD8α chain transmembrane and lumenal domains (CD8) with HIV-1 NL4.3 Vpu, Nef or Nef-LL/AA. B, Surface expression of CD8 constructs in HeLa P4.R5 cells. Cells were cotransfected to express CD8-, CD8-Vpu, CD8-Nef or CD8-Nef-LL/AA, together with a GFP expression construct as a transfection marker. Cell surface CD8 was stained with fluorescent antibody and the cells analyzed by 2-color flow cytometry. The graph indicates the MFI of surface CD8 staining in the GFP-positive cell population, error bars represent the SD of 3 independent experiments. C, Representative 2-color plots of CD8 expression in GFP-positive cells are shown. D, Expression of the CD8 chimeras was measured in cell lysates subjected to SDS-PAGE and western blotting. Control samples contain GFP-transfected cells only. E, The endocytic rates of the CD8-chimeras were measured in HeLa P4.R5 cells. Cells expressing CD8, CD8-VpuCD, CD8-Nef or CD8-Nef-LL/AA and a GFP expression construct were labeled for surface CD8 using a primary anti-CD8 antibody while on ice. The cells were warmed to 37 C for the indicated time-points, and remaining surface CD8 antibody was detected by fluorophore-conjugated secondary antibody staining and 2-color flow cytometric analysis. The endocytic rate of endogenous TfnR was also measured using the same method. Data are normalized to the 0-time-point control (cells not warmed before secondary staining), and presented as the percentage of CD8 remaining on the cell surface over time. Error bars indicate SD of 3 independent experiments. F, Two-color plots of the time course of CD8-Vpu surface staining in GFP-positive cells are shown. G, The rate of surface replenishment of the CD8-chimeras measured in HeLa P4.R5 cells. Surface CD8 was blocked using unconjugated anti-CD8 antibody while the cells were on ice. The cells were warmed to 37 C for the indicated time points and CD8 newly deposited at the cell surface was labeled with fluorophore-conjugated anti-CD8
antibody. Data are the mean fluorescence intensity of CD8 in GFP-positive cells; error bars indicate the SD of 2 independent experiments. Representative 2-color plots of CD8-Vpu surface replenishment over time are shown in (H) transferrin receptor (TfnR), an endogenous marker for clathrinmediated endocytosis and recycling. For endocytosis assays, surface CD8 or TfnR were labeled at 4 C with primary antibodies before warming to 37 C for the indicated time-points, and antibody remaining at the cell surface was detected by staining with an immunofluorescent secondary antibody. The MFI of CD8 or TfnR was normalized to the zero time-point and is presented as the percentage remaining on the cell surface over time ( Figure 1E ,F). CD8-VpuCD and CD8-Nef were rapidly endocytosed from the cell surface, with a 61% loss in CD8-VpuCD and a 38% loss in CD8-Nef signal observed after the first 2 minutes of incubation at 37 C. TfnR was also rapidly endocytosed, as anticipated. In contrast, little or no endocytic activity was observed for truncated CD8-and CD8-Nef-LL/AA; these proteins essentially remained at the cell surface. Fusion of CD8 with the CD of clade C Vpu (MJ4 or 96BW clones) resulted in rapid endocytosis, at rates similar to that induced by the CD the Vpu clade B clone NL4.3 ( Figure S1 ).
Although the TMD of Vpu is the main mediator of the protein's interaction with cellular targets, the CD of Vpu contributes to the interaction with CD4. 30 To exclude a contribution of CD4 to the endocytic rate of CD8-Vpu, we repeated these experiments in HeLa-Z24 cells, 31 a precursor line to HeLa-P4.R5, which do not express CD4 ( Figure S2 ). The rates of endocytosis of CD8-Vpu were equivalent in the 2 cell types, indicating that CD4 was not a major determinant of endocytic rate.
The kinetics of surface-deposition of the CD8 chimeras were also studied in transiently transfected HeLa-P4.R5 cells by flow cytometry. Surface CD8 was labeled at 4 C using unconjugated primary anti-CD8 antibody to block all available sites on the cell surface; the cells were warmed to 37 C for the indicated times; and CD8 newly deposited at the cell surface was detected using fluorophore-conjugated primary anti-CD8 antibody ( Figure 1G ,H). CD8-VpuCD and CD8-Nef were rapidly deposited at the cell surface, whereas CD8-and CD8-Nef-LL/AA were deposited at a much slower rate.
These data demonstrate that the Vpu CD, like Nef, contains potent endocytic determinants, evident by its ability to confer trafficking activity to the otherwise inert truncated CD8 α chain. Moreover, the rapid rate of internalization of CD8-VpuCD and its similarity to that of TfnR suggest that the VpuCD, like Nef, drives internalization through a clathrin-mediated endocytic pathway. Finally, the rapid rates of surface-deposition of CD8-VpuCD and CD8-Nef, in contrast to the slow rate of surface-deposition of truncated CD8 and CD8-Nef-LL/AA, suggest that the rapid endocytosis driven by Vpu and
Nef is potentially associated with a rapid rate of recycling.
| CD8-VpuCD accumulates in recycling-and late-endosomes
The subcellular localization of the CD8-chimeras was investigated in HeLa-P4.R5 cells using immunofluorescence (IF) microscopy. Microscopic analysis revealed that CD8-VpuCD and CD8-Nef accumulated in enlarged vesicles, while CD8-and CD8-Nef-LL/AA were restricted to the plasma membrane (Figure 2A ). Given the rapid rate of endocytosis and surface-deposition of CD8-VpuCD, we hypothesized that the protein would colocalize with markers of the clathrin-mediated endolysosomal pathway as well as with markers of recycling endosomes. To test this, HeLa-P4.R5 cells were either transfected to express CD8- We next investigated whether the clathrin adaptor AP-2 was required for internalization of the CD8-VpuCD chimera. We targeted the AP-2 α subunit for siRNA-mediated knockdown; depletion of any one of the AP complex subunits decreases stability of the remaining subunits and results in inactive, partial complex formation. [32] [33] [34] HeLa-P4.R5 cells were transfected with siControl or siRNA targeted to AP-2 α (siAP-2α). After 48 hours, the cells were transfected to express the CD8-chimeras and GFP, and steady-state surface-expression and endocytic rate were measured the next day, as described above. The MFI of surface CD8 at steady-state is shown in Figure 4A . Internalization rates normalized to steady-state (the 0-time-point controls) for each chimera are shown in Figure 4B ,C.
Depletion of AP-2 resulted in a modest, but statistically significant, increase in the surface expression of CD8-VpuCD at steady-state.
However, the rate of internalization of CD8-VpuCD was reduced to near that of truncated CD8-and CD8-Nef-LL/AA. In contrast, AP-2 depletion substantially and significantly increased the surface expression of CD8-Nef at steady-state, and the rate of internalization was indistinguishable from that of CD8-or CD8-Nef-LL/AA. AP-2 knockdown was confirmed by western blotting of cell lysates with probing for α-adaptin ( Figure 4D ). These data indicate that AP-2 is the critical clathrin adaptor co-opted by both the Vpu CD and Nef to mediate endocytosis. The data also indicate that although the surfaceexpression of CD8-Nef at steady state is mainly determined by AP-2-mediated endocytosis, this is not true of CD8-VpuCD; AP-2 depletion increased the surface levels of CD8-VpuCD less effectively than clathrin-depletion (compare Figures 3 and 4 ). These findings suggest that a clathrin adaptor in addition to AP-2 contributes to trafficking mediated by the Vpu CD. That adaptor seems unlikely to be AP-1, because suppression of AP-1 expression by siRNA targeting γ-adaptin (the large, specific subunit of AP-1) had no effect on either the surface-expression of CD8-VpuCD at steady state or its rate of endocytosis ( Figure S4 ).
The subcellular localization of CD8-VpuCD was examined in HeLa-P4.R5 cells transfected with siControl or siAP-2α. The cells were transfected to express CD8-VpuCD 48 hours after treatment with the siRNAs, and then fixed and stained the following day. CD8-VpuCD was detected using antibody to CD8, and cells depleted of AP-2 were identified using antibody to α adaptin ( Figure 4E ). The distribution of CD8-VpuCD in the control siRNA-treated cells was predominantly vesicular, as previously noted, with little colocalization with α adaptin. In AP-2 depleted cells, however, CD8-VpuCD was detectably displaced to the plasma membrane, a result consistent with the role of AP-2 in the endocytosis of the protein but somewhat unexpected given the modest increase in cell-surface expression measured by flow cytometry as discussed above.
Given the discordant effects of AP-2-depletion on the steady state surface level of CD8-Vpu (modest) and on the rate of endocytosis of CD8-Vpu (substantial), we examined the role of AP-2 in the subcellular localization of full-length Vpu ( Figure 4F ). Like CD8-Vpu, shown interacts with AP-1 σ and γ subunits in an extended conformation. 23 Recently, serines at positions 52 and 56, which when phosphorylated bind β-TrCP and recruit a cullin1-based ubiquitin ligase complex, have been shown to contribute to interactions between Vpu and AP-1 and AP-2; these AP-interactions require not only serine phosphorylation but reportedly also the interaction of Vpu with one of its cellular targets, BST-2. 24 To identify which of these sequences contribute to endocytosis, we introduced mutations to inactivate them, either singly or in combination, in the context of the CD8-VpuCD chimera. Endocytic rates were measured as described above and are presented as the percentage remaining at the cell surface over time ( Figure 5A ,B). Surface levels of CD8 at steady state are shown in Figure 5C .
Mutations of single potential motifs modestly affected the surface levels of CD8-VpuCD at steady state; each sequence contributed a modicum of overall internalization activity. These results
FIGURE 3
Endocytosis of CD8-Vpu-CD is sensitive to siRNA-mediated depletion of clathrin. A, The rates of internalization of the truncated CD8-, CD8-VpuCD, CD8-Nef or CD8-Nef-LL/AA were measured in clathrin-depleted HeLa P4.R5 cells by flow cytometry. The cells were transfected with siRNA oligonucleotides directed against Clathrin (siClathrin) or a non-targeting control (siControl). After 48 hours, the cells were transfected to express the indicated CD8-chimeras and a GFP expression construct. After 24 hours, the internalization rates of the CD8-chimeras were measured by antibody labeling and flow cytometric analysis. Steady state surface levels of CD8-chimeras are shown (0-timepoint control). B and C, Data were normalized to the 0-time-point control and presented as the percentage surface CD8 remaining over time, in either siControl-treated (B) or clathrin-depleted (C) cells. Error bars indicate the SD of 3 independent experiments. P-values were generated by paired 2-tailed t test, *P < .05, **P < .001. D, Protein from cell lysates was separated by SDS-PAGE and clathrin depletion confirmed by western blotting. E, The intracellular localization of CD8-VpuCD was determined by widefield microscopy of HeLa P4.R5 cells transfected with negative control or clathrin siRNA. To identify clathrin depleted cells with impaired endocytosis, cells were serum-starved prior to uptake of fluorescent transferrin (red) for 30 minutes; the cells were then fixed and counterstained for CD8 (green). Scale bars = 10 μm regarding the VpuCD are in contrast to Nef, in which the leucinebased motif contributed the entirety of internalization activity. Mutations of single potential motifs also affected only modestly the endocytic rate of CD8-VpuCD. The combination of the Y29A with either the S52,56N or ELV/AAA substitutions significantly inhibited endocytic rate, and the triple mutant Y29A-ELV/AAA-S52,56N was devoid of endocytic activity. Total cellular expression of the chimeras was measured by western blot; all the constructs were similarly expressed, aside from truncated CD8-, as previously observed ( Figure 5D ). The triple combination mutant was also characterized by IF microscopy ( Figure 5E ). While CD8-VpuCD accumulated in enlarged intracellular vesicles as shown above, the triple mutant Y29A-ELV/AAA-S52,56N was displaced to the plasma membrane, similar to truncated CD8. Together, these data suggested that the ability of the Vpu CD to direct endocytosis requires multiple determinants whose functional roles are additive.
| Roles of clathrin and AP-2 in the Vpumediated downregulation of surface BST-2
To assess the functional roles of clathrin and clathrin adaptors as cofactors of the complete Vpu protein, we measured the surface FIGURE 4 Endocytosis of CD8-Vpu-CD is sensitive to siRNA-mediated depletion of AP-2. A, The rates of internalization of the truncated CD8-, CD8-VpuCD, CD8-Nef or CD8-Nef-LL/AA were measured in AP-2-depleted HeLa P4.R5 cells by flow cytometry. The cells were transfected with siRNA oligonucleotides directed against AP-2 α subunit (siAP-2α) or a non-targeting control (siControl). After 48 hours, the cells were transfected to express the indicated CD8-chimeras and a GFP expression construct. After 24 hours, the internalization rates of the CD8-chimeras were measured by antibody labeling and flow cytometric analysis. Steady state surface levels of CD8-chimeras are shown (0-time-point control). Data were normalized to the 0-time-point control and presented as the percentage surface CD8 remaining over time, in either siControl (B) or siAP-2α (C) treated P4.R5 cells. Error bars indicate the SD of 3 independent experiments. P-values were generated by paired 2-tailed t test, *P < .05, ***P < .001. D, Protein from cell lysates was separated by SDS-PAGE and AP-2α depletion confirmed by western blotting. E, The intracellular localization of CD8-VpuCD was determined by microscopy of HeLa P4.R5 cells transfected with negative control or AP-2α siRNA. Cells were transfected with CD8-VpuCD, and 24 hours later fixed and stained for immunofluorescence. AP-2α depletion in these cells was determined by primary antibody labeling of AP-2α and fluorescent secondary detection (red); CD8 staining is shown in green. F, The intracellular localization of full-length Vpu was determined by microscopy of HeLa P4.R5 cells depleted of clathrin or AP-2α. Cells were transfected with Vpu-FLAG 48-hour posttreatment with siRNAs, fixed and immunofluorescently-stained for FLAG. Scale bars = 10 μm levels of BST-2 in HeLa-P4.R5 cells, which express endogenous BST- Primary data from a representative experiment are shown in Figure 6C . Depletion of clathrin inhibited the downregulation of BST-2, which was anticipated, given the ability of a dominant-negative version of the clathrin-assembly cofactor AP180 to inhibit this activity. 21, 22, 24 Depletion of AP-2 inhibited the downregulation of BST-2 to a lesser extent then depletion of clathrin, although these effects were statistically significant (P < .001). The role of AP-2 in the downregulation of BST-2 has been previously reported. 20 Surface BST-2 downregulation appeared insensitive to depletion of AP-1. We also reassessed the functional roles of the Vpu sequences Y 29 RKI, S52,S56, and EL 63 V, both alone and in combination ( Figure 6D ,E). These data largely supported those previously reported, but they also indicated new relationships. The S52,56N and ELV/AAA substitutions each substantially impaired the downregulation of BST-2; moreover, their effects appeared additive ( Figure 6D ). The Y29A substitution had no effect on the downregulation of BST-2, consistent with previous results, but nonetheless surprising given its contribution to the endocytic rate of the CD8-VpuCD chimera. 21 The additive effect of the S52,56N and ELV/AAA substitutions on BST-2 downregulation was lost in the presence of the Y29A substitution. These data suggest that a phenotype for the Y29A substitution might be revealed in certain genetic contexts, but the role played by this residue in Vpu-activity is currently obscure.
2.6 | Phosphorylation regulates direct interactions of the Vpu CD with subunits of AP-1 and AP-2
We considered that one way in which the Vpu serines and the membrane proximal tyrosine might contribute to clathrin-and AP-2-dependent trafficking would be through the interaction of the Vpu CD with the medium (μ) subunit of the complex. We previously reported a weak interaction between the Vpu CD and the μ subunits of AP-1 (μ1) and AP-2 (μ2), but not AP-3 (μ3), detected using recombinant proteins and size-exclusion chromatography. 23 Here, we tested the hypothesis that the Vpu CD bound to μ subunits in a tyrosine-and serine-phosphorylation-dependent manner using partly purified, recombinant glutathione-S-transferase (GST)-Vpu and maltose-binding-protein (MBP)-μ fusion proteins produced in Escherichia coli in pull-down assays ( Figure 7) . As shown previously, the Vpu-CD bound μ1 and μ2, but not μ3 ( Figure 7A ). The interactions with μ1 and μ2 required phosphorylation of the Vpu-CD, which we induced by coexpressing both subunits of casein-kinase II (CK-II) along with the GST-Vpu in the E. coli cells and which we confirmed using an antibody specific for detection of phosphorylated Vpu
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( Figure 7B ). The interaction of phosphorylated Vpu-CD with μ2 was surprisingly independent of tyrosine-29 and isoleucine-32; the interaction with μ1 was partly dependent on tyrosine-29 but independent of isoleucine-32 ( Figure S5 ). These results weighed against the hypothesis that Y29 functions as part of an Yxxφ AP-binding motif
The interaction of phosphorylated Vpu-CD with μ1 and μ2 was dependent on serines 52 and 56 ( Figure 7C ), and μ2 binding was independent of the ExxxLV motif, as anticipated ( Figure 7D ). The Vpu CD also bound to an AP-2 hemicomplex formed of α/σ2 subunits, and this association was enhanced by phosphorylation of serines 52 and 56 ( Figure 7D ), as proposed previously. 24 The interaction of phosphorylated serines 52 and 56 with μ1 and μ2 supported the hypothesis that these residues, which are surrounded by several aspartates and glutamates, are part of a phosphorylation-regulated acidic cluster AP-binding motif, such as that found in the trans Golgi network (TGN)-resident cellular protease furin. 36 The mode of binding of such motifs to AP complexes is FIGURE 6 Legend on next column. experiments. E, Cell lysates were subject to SDS-PAGE and western blotting controversial; some evidence supports phosphofurin acidic cluster sorting (PACS) proteins as intermediaries between the acidic cluster and the AP complexes, whereas other evidence supports direct binding of the acidic cluster to the μ subunits, which have a positive (basic) electrostatic potential. [37] [38] [39] We previously identified 2 basic patches on μ1 that interact with acidic residues either within HIV-1
Nef or within the CD of one of its cellular targets, the MHC-I α-chain. 25 Basic residues at these sites are present in μ2 as well as μ1, but they are not present in μ3 (Figure 7E,F) . Alanine substitution of these basic residues abrogated the interaction between phosphoVpu and μ1 and μ2 ( Figure 7G ). These data support the notion that the S52,S56 region of Vpu plays 2 roles: in addition to acting as a "phosphodegron" that recruits β-TrCP and a cullin1-based ubiquitin- TMD of the CD8 α-chain, we aimed to study the autonomous contribution of motifs in the Vpu CD to membrane trafficking activity. This strategy is not without caveats. The missing Vpu TMD renders CD8-VpuCD unlikely to interact with most cellular targets of Vpu, and we experimentally determined that the presence of CD4 did not influence CD8-VpuCD-trafficking, but we cannot exclude that unknown cellular targets of Vpu might influence the behavior of this chimera.
Moreover, the oligomerization state of CD8-VpuCD might be different than native Vpu: CD8 is a dimer, and once cross-linked with antibody seems probably to behave as a tetramer, whereas Vpu may exist as a tetramer or pentamer. 40, 41 On the other hand, by fusing the CD of Vpu to GST for pull-down assays using recombinant proteins, we unambiguously studied the autonomous contributions of these motifs to the interaction with subunits and hemicomplexes of AP-1 and AP-2.
The data suggest that the Vpu CD contains determinants that Vpu, but with a potentially important exception: whereas CD8-Vpu is endocytosed in an AP-2-dependent manner, Vpu is not known to substantially increase the rate of endocytosis of its targets. 20, [42] [43] [44] These considerations lead to the hypothesis that rather than stimulating target endocytosis, endocytic motifs in the Vpu CD are required to send Vpu along an itinerary appropriate to finding and interacting with its targets within the endosomal system; then, once in complex with those targets, the same motifs participate in their intracellular retention or degradation.
The trafficking properties of the VpuCD were similar but not identical to those of HIV-1 Nef. The surface expression of both CD8-VpuCD and CD8-Nef were comparatively low at steady state, which was attributable to sequestration in endosomal compartments including late endosomes. The Vpu CD, like Nef, stimulated rapid rates of endocytosis and surface deposition, which occur on a time-scale of minutes. On the other hand, knockdown of AP-2 markedly upregulated the expression of CD8-Nef on the cell surface at steady state, but it had much less an effect on the steady state surface expression of CD8-VpuCD.
The association of Vpu with the host membrane trafficking machinery is key to its function. BST-2 antagonism is clathrindependent, but exactly how has been unclear. [20] [21] [22] We reported a role for AP-2 in the Vpu-mediated surface-downregulation of BST2, 20 and a dominant negative version of the clathrin assembly factor AP180 inhibits the ability of Vpu to downregulate cell surface BST-2 and to counteract BST-2-mediated restriction of virionrelease. 21, 22 However, others have reported that Vpu-mediated counteraction of virion-restriction by BST-2 was insensitive to knockdown of AP-1, -2 or -3, and AP-1γ knockout in mouse fibroblasts had no apparent effect on the ability of Vpu to downregulate BST2. 22 Here, we observed that Vpu-mediated downregulation of surface BST-2 was sensitive to depletion of clathrin and to a much lesser extent AP-2. Thus, our data support the role of clathrin in Vpu function, but they leave unanswered the role of AP-1, and, as elaborated below, they suggest that AP-2 is insufficient as a Vpu-cofactor that explains the protein's functional dependence on clathrin.
As the knockdown conditions for both clathrin and AP-2 were sufficient to abrogate the endocytosis of CD8-VpuCD and CD8-Nef, Vpu binds AP-1 and AP-2 subunits in a serine-phosphorylation-dependent manner. A, Phosphorylated Vpu binds μ1 and μ2 but not μ3 in vitro. Phosphorylated GST-tagged VpuCD recombinant protein was purified from Escherichia coli cotransformed to express CK-II. The GSTVpuCD was mixed with MBP-μ1, -μ2 or -μ3 before GST pulldown. Bound proteins were analyzed by SDS-PAGE and Coomassie staining. B, Phosphorylation of GST-VpuCD by coexpression with CK-II was confirmed by western blot using an antibody which specifically detects Vpu phosphorylated at serines 52 and 56. C, Phosphorylation of serines 52 and 56 is required for μ1 and μ2 binding. GST-pulldown of μ1 and μ2 was evaluated using Vpu, Vpu-S52/56N or Vpu and Vpu-S52/56N produced in the presence of CK-II. D, Phosphorylation of serines 52 and 56 increases Vpu's binding affinity for both the AP-2 α-σ2 hemicomplex and μ2. GST-pulldown of AP-2 μ2 and α-σ2 was evaluated using either Vpu, or phosphorylated Vpu or the indicated Vpu mutants produced in the presence of CK-II. E, Analogous basic residues present in μ1 and μ2, but not μ3, as shown in a structure-based sequence alignment. F, These basic residues occupy similar regions in μ1 and μ2; positively charged residues are shown in blue, negative in red. G, Basic residues in μ1 and μ2 are required for binding phosphorylated Vpu. GST pulldown was performed between phosphorylated Vpu and μ1 or μ2 containing substitutions within the 2 indicated sets of basic residues; R225, R393/AA and K274, K298, K302, R303/EEED in μ1, and equivalent residues K227, R402/AA and K308, K312/EE in μ2
proteins. [45] [46] [47] [48] Alternatively, we have not excluded that Vpu binds directly to clathrin, an hypothesis supported by experiments in which a "clathrin-box" appended to the C-terminus of Vpu rescues mutations within the CD that impair counteraction of BST-2-mediated restriction of virion release. 24 Multiple determinants within the CD of Vpu are required to drive clathrin-and AP-2-dependent endocytosis, and the activity of these determinants is additive. This contrasts with endocytosis driven by Nef, which we confirmed relies solely on an intact leucine-based APbinding motif. 28, 49 In How do the phosphoserines in the Vpu CD mediate interactions with the AP complexes? In support of a recent hypothesis that phosphorylation of the serines might lead to conformational changes that render the ExxxLV motif more active, we observed that the ExxxLVmediated interaction with the α/σ2 hemicomplex of AP-2 was enhanced by serine phosphorylation. 24 But strikingly, our data indicate an alternative and novel mode of binding. We found that the recombinant Vpu CD binds both μ1 and μ2, but not μ3, and that this interaction requires serine phosphorylation within the DpS 52 GxxpS 56 sequence.
With regard to μ binding, we hypothesize that these serines in Vpu, which are surrounded by several aspartates and glutamates, are part of a phosphorylation-regulated acidic cluster AP-binding motif, such as that found in the TGN-resident cellular protease furin and mannose-6-phosphate receptors. 36, 53 Furin, in particular, contains a very similar motif (SDSEED), which regulates localization to the TGN in a phosphorylation-dependent manner. 54 Acidic clusters containing CK-II phosphorylation sites are commonly found in cellular proteins which cycle between the TGN and endosomes, 55 and we propose that Vpu is a viral protein with similar properties. Direct and indirect associations of these acidic cluster motifs with AP complexes have been proposed, the former through the μ subunits via their positive surface electrostatic potential, and the latter through an intermediate protein, the PACS protein-I (PACS-I). 37 Our in vitro binding studies support the model of direct interaction between the Vpu acidic cluster and μ subunits. In further support and elaboration of this model, we found that 2 basic patches on μ1 were required for phosphoVpu-binding. These basic patches are the same ones that we identified in the Nef/MHC-I CD/μ1 complex: one recognizes the "acidic cluster" within Nef (E 62 -E 65 ), and the other recognizes acidic residues from both Nef and the MHC-I CD. 25 The analogous basic patches on μ2 were also essential for interaction with the Vpu CD, and these seem probably to explain the role of the phosphoserine motif in endocytosis. Neither of these basic patches is apparent on the surface of μ3, consistent with the lack of binding of the Vpu CD to μ3.
The role of these basic patches on μ1 and μ2 reveals a remarkable unlikely to fit this model, however, because although the modulation of CD4 by Vpu is completely dependent on the phosphoserines, this activity has been attributed to recruitment of a cullin1-based E3 ligase via β-TrCP rather than to the recruitment of clathrin adaptors. 14, 16 In summary, we propose that the serines of the Vpu 
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. 60 Single and combination mutations of VpHu in the context of pCINeo-CD8-VpHu-CD or pcDNA3.1-VpHu-FLAG plasmids were generated by QuikChange site-directed mutagenesis PCR.
All primers were synthesized by Integrated DNA Technologies and constructs were confirmed by sequencing using Genewiz services.
siRNA targeting AP-2α subunit was obtained from Dharmacon, the siRNA target sequence was AAGAGCAUGUGCACGCUGGCCA. 
| Flow cytometry
To assess levels of surface expression of the CD8-chimeras at steady state, transfected HeLa P4.R5 cells were washed and resus- for 30 minutes on ice, to detect CD8 remaining at the cell surface.
The cells were washed and fixed in 2% PFA before analysis.
| Surface-deposition assay
HeLa-P4.R5 cells were seeded in 6-well plates, 2 wells per condition.
The cells were transfected with the indicated CD8-chimeras. After 
| Western blot
Cell monolayers were washed with PBS and lysed in ice-cold extraction buffer (0.5% Triton X-100, 150 mM NaCl, 25 mM KCl, 25 mM Tris, pH 7.4, 1 mM ethylenediaminetetraacetic acid) supplemented with a protease inhibitor mixture (Roche Applied Science). Extracts were clarified by centrifugation (12 000g for 10 minutes at 4 C).
The sample protein concentration was determined by Bradford assay (BD Biosciences) using standard protocols, and 10 μg denatured by boiling for 5 minutes in SDS sample buffer. Proteins in the extracts were resolved by SDS-PAGE using 12% acrylamide gels, The phosphoryation of Vpu was confirmed using phosphoserine Vpu-specific antibodies. 35 Vpu-CD mutants Y29A, I32A and S52,56N were similarly cloned, expressed and purified in both nonphosphorylated and phosphorylated forms. Mutations were introduced using the QuikChange PCR mutagenesis kit and confirmed by DNA sequencing. Expression and purification of μ1 (158-423), μ2 (159-435) and AP-2 hemicomplex α(1-398)/σ2(1-142) proteins was performed as previously described. 25 Substitutions were introduced in 2 regions of basic residues: R225, R393/AA and K274, K298, K302, R303/EEED in μ1, and equivalent residues K227, R402/AA and K308, K312/EE in μ2, using QuikChange PCR mutagenesis. The pMAT9s-μ1 and pMAT9s-μ2 plasmids were coexpressed with the pGro7 vector (Takara Bio), which encodes the groES and groEL chaperone proteins, in E. coli BL21(DE3) cells in Terrific Broth. 2 mg/mL L-(+)-Arabinose was added to induce chaperone expression. Expression of MBP-μ1 and MBP-μ2 was induced by 0.1 mM IPTG at A600 of 0.6 and continued at 16 C overnight.
The proteins were purified to homogeneity by using Ni-NTA gravity flow, HiTrap SP cation exchange column and Sephadex 200 gel filtration column.
| In vitro binding assays using GST-pulldown
The purified recombinant proteins were mixed in equimolar ratio at 35 μM protein concentration in a final volume of 100 μL. These protein mixtures were then incubated with 100 μL Glutathione Sepharose 4B resin overnight at 4 C. The next morning, the resin was washed with GST-binding buffer (20 mM Tris pH 7.5, 150 mM NaCl)
to remove unbound proteins. After extensive washing, the bound proteins were eluted using 100 μL of GST elution buffer (50 mM Tris pH 8.0, containing 10 mM reduced glutathione). The proteins were analyzed by SDS-PAGE and Coomassie staining.
